University Hospital, Lille

• NCT07542990

  Collaborator, Phase 3, Not yet recruiting, 266 people, 21 Apr 2026

• NCT07037043

  Collaborator, Phase 3, Recruiting, 196 people, 25 Jun 2025

• NCT06956482

  Phase 3, Recruiting, 477 people, 4 May 2025

• NCT05817851

  Collaborator, Phase 2, Recruiting, 234 people, 18 Apr 2023

• NCT04570085

  Phase 3, Recruiting, 248 people, 30 Sept 2020

• NCT04289805

  Collaborator, Phase 4, Terminated, 96 people, 28 Feb 2020

• NCT03293069

  Phase 2/3, Completed, 372 people, 26 Sept 2017

• NCT03243175

  Phase 3, Recruiting, 300 people, 8 Aug 2017

• NCT03243019

  Phase 2, Recruiting, 28 people, 8 Aug 2017

• NCT03158376

  Phase 3, Completed, 201 people, 18 May 2017

• NCT02969733

  Phase 2/3, Completed, 135 people, 21 Nov 2016

• NCT02891395

  Phase 2, Completed, 65 people, 7 Sept 2016

• Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period

  Collaborator, Phase 3, Completed, 47 people, 29 Jul 2016

• NCT02783430

  Phase 2/3, Completed, 42 people, 26 May 2016

• NCT02662504

  Phase 2, Completed, 6 people, 25 Jan 2016

• NCT02655315

  Phase 2, Completed, 372 people, 14 Jan 2016

• NCT02626481

  Phase 2, Completed, 64 people, 10 Dec 2015

• NCT02567279

  Collaborator, Phase 3, Terminated, 2 people, 2 Oct 2015

• NCT02302495

  Phase 2, Completed, 32 people, 27 Nov 2014

• NCT02288000

  Phase 1, Terminated, 30 people, 11 Nov 2014

Sources: clinicaltrials.gov